Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
LifeStance Health Group Inc (NASDAQ: LFST) closed the day trading at $6.49 up 2.85% from the previous closing price of $6.31. In other words, the price has increased by $2.85 from its previous closing price. On the day, 1.76 million shares were traded. LFST stock price reached its highest trading level at $6.52 during the session, while it also had its lowest trading level at $6.27.
Ratios:
For a better understanding of LFST, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.22. In the meantime, Its Debt-to-Equity ratio is 0.35 whereas as Long-Term Debt/Eq ratio is at 0.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on January 03, 2024, initiated with a Underweight rating and assigned the stock a target price of $7.
On May 15, 2023, TD Cowen Downgraded its rating to Market Perform which previously was Outperform and also upped its target price recommendation from $8 to $9.
Morgan Stanley Upgraded its Equal-Weight to Overweight on January 06, 2023, while the target price for the stock was maintained at $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 23 ’24 when Varanakis Ann sold 5,269 shares for $6.28 per share. The transaction valued at 33,089 led to the insider holds 263,007 shares of the business.
KEVIN M MULLINS bought 1,400,000 shares of LFST for $8,041,600 on Aug 21 ’24. On Aug 20 ’24, another insider, KHAN PARENTS TRUST LLC C/O DAN, who serves as the Former Officer of the company, bought 43,392 shares for $5.72 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFST now has a Market Capitalization of 2483223296 and an Enterprise Value of 2893574400. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.15 while its Price-to-Book (P/B) ratio in mrq is 1.74. Its current Enterprise Value per Revenue stands at 2.503 whereas that against EBITDA is 508.09.
Stock Price History:
Over the past 52 weeks, LFST has reached a high of $9.20, while it has fallen to a 52-week low of $4.64. The 50-Day Moving Average of the stock is 16.93%, while the 200-Day Moving Average is calculated to be 3.13%.
Shares Statistics:
Over the past 3-months, LFST traded about 1.58M shares per day on average, while over the past 10 days, LFST traded about 1609070 shares per day. A total of 378.73M shares are outstanding, with a floating share count of 111.07M. Insiders hold about 70.97% of the company’s shares, while institutions hold 32.67% stake in the company. Shares short for LFST as of 1723680000 were 12223183 with a Short Ratio of 7.75, compared to 1721001600 on 15813285. Therefore, it implies a Short% of Shares Outstanding of 12223183 and a Short% of Float of 15.290000000000001.
Earnings Estimates
A detailed examination of LifeStance Health Group Inc (LFST) is currently in progress, with 7.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.21 and -$0.26 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$0.17, with 7.0 analysts recommending between -$0.1 and -$0.22.
Revenue Estimates
For the next quarter, 6 analysts are estimating revenue of $310.55M. There is a high estimate of $313.5M for the next quarter, whereas the lowest estimate is $308M.
A total of 8 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $1.23B, while the lowest revenue estimate was $1.22B, resulting in an average revenue estimate of $1.22B. In the same quarter a year ago, actual revenue was $1.06BBased on 8 analysts’ estimates, the company’s revenue will be $1.38B in the next fiscal year. The high estimate is $1.42B and the low estimate is $1.35B.
